Innate and acquired immunity responses are crucial for viral infection elimination. However,
genetic variations in coding genes may exacerbate the inflammation or initiate devastating …

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …

Importance Currently, disease-modifying therapies for multiple sclerosis (MS) use 4
mechanisms of action: immune modulation, suppressing immune cell proliferation, inhibiting …

Three reports address the protection of the vulnerable population of patients with
hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest …

Longitudinal studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine-induced immune responses in patients with cancer are needed to optimize clinical …

Prolonged infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
immunocompromised patients provides an opportunity for viral evolution, potentially leading …

Background The immunogenicity of COVID-19 vaccine among patients receiving anti-CD20
monoclonal antibody (Ab) treatment has not been fully investigated. Detectable levels of …

PURPOSE Patients with non-Hodgkin lymphoma including chronic lymphocytic leukemia
(NHL/CLL) are at higher risk of severe SARS-CoV-2 infection. We investigated vaccine …

Patients with hematological malignancies (HMs) are at a higher risk of develo** severe
form and protracted course of COVID-19 disease. We investigated whether the combination …

Profoundly B-cell-depleted patients can have prolonged severe acute respiratory syndrome
coronavirus 2 infections with evidence of active viral replication, due to inability to mount an …